Ibrance 125 MG capsule 21S
Ended Awarded Last action
- Contract number
- SPE2DR26F18XV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,221
Award facts
- Contract value 100% obligated
- $34,220.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $34,220.84 to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg capsules (21-count) on December 3, 2025, with an ultimate completion date of December 24, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion comprehensive pharmaceutical supply agreement running through December 2026 that enables the company to distribute a wide range of pharmaceuticals and medical supplies to support military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal vendor for military and veteran healthcare procurement. The company has established itself as a reliable supplier through multiple delivery orders under its DLA prime contract vehicle, consistently demonstrating capability to fulfill federal medical supply requirements through open competition. This specific delivery order for Ibrance, an oncology medication, reflects the company's role in supporting the Defense Health Agency and broader military healthcare operations with essential brand-name pharmaceutical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F18XV?
SPE2DR26F18XV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26F18XV worth?
The government has obligated $34,221 on SPE2DR26F18XV.
Is contract SPE2DR26F18XV an order under another contract?
Yes. SPE2DR26F18XV is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F18XV competed?
The extent of competition for SPE2DR26F18XV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award